InvestorsHub Logo
Followers 0
Posts 749
Boards Moderated 0
Alias Born 09/14/2017

Re: Paulness post# 2548

Monday, 04/30/2018 8:59:29 AM

Monday, April 30, 2018 8:59:29 AM

Post# of 2719

Cytori Provides Update on US Manufacturing and EU Approval Plans for ATI-0918, Liposomal Doxorubicin



This is important, because there is not any generic competition.

It's way more important than any other Cytori product.